The Future of Telemedicine in Oncology
Plain-language summary
This article discusses how the COVID-19 pandemic drove a large surge in telemedicine use in oncology, with usage later settling below its early-pandemic peak but above pre-pandemic levels. The authors note that most oncology providers view telemedicine as beneficial and likely to stay, but point to barriers that hinder equitable delivery, including older age, rural residence, lower socioeconomic status, and racial/ethnic disparities. They argue that addressing these disparities, expanding broadband access, and educating both patients and providers are essential to telemedicine's future in cancer care.
Read the full paper (DOI: 10.6004/jnccn.2022.5020).
This is a plain-language summary written for discoverability; the authoritative version is the published paper. Part of Travis Osterman's peer-reviewed publications.